| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of EHMT2 mRNA | affects expression | 21346803
|
| C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of EHMT2 mRNA | decreases expression | 18648102
|
| D000082 |
Acetaminophen |
Acetaminophen affects the expression of EHMT2 mRNA | affects expression | 17562736
|
| C015001 |
arsenite |
arsenite results in increased expression of EHMT2 mRNA | increases expression | 18321869
|
| C015001 |
arsenite |
arsenite results in increased expression of EHMT2 protein | increases expression | 18321869
|
| D001241 |
Aspirin |
Aspirin results in increased expression of EHMT2 mRNA | increases expression | 11906190
|
| C518299 |
BIX 01294 |
BIX 01294 results in decreased activity of EHMT2 protein | decreases activity | 19531572
|
| C014347 |
decitabine |
EHMT2 protein affects the susceptibility to decitabine | affects response to substance | 19531572
|
| D004317 |
Doxorubicin |
Doxorubicin promotes the reaction [EHMT2 protein binds to BIRC5 promoter] | affects binding|increases reaction | 17124180
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of EHMT2 mRNA | increases expression | 17942748
|
| D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EHMT2 mRNA | affects cotreatment|increases expression | 17942748
|
| D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of EHMT2 mRNA | affects cotreatment|increases expression | 17183730
|
| D007657 |
Ketone Bodies |
Ketone Bodies results in increased expression of EHMT2 mRNA | increases expression | 16807920
|
| D009532 |
Nickel |
Nickel results in decreased expression of and results in decreased activity of EHMT2 protein | decreases activity|decreases expression | 16648469
|
| D010126 |
Ozone |
Ozone results in decreased expression of EHMT2 mRNA | decreases expression | 17460151
|
| D013467 |
Sulindac |
Sulindac results in decreased expression of EHMT2 mRNA | decreases expression | 11906190
|
| D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EHMT2 mRNA | affects cotreatment|increases expression | 17942748
|
| D014212 |
Tretinoin |
EHMT2 protein promotes the reaction [Tretinoin promotes the reaction [CBX1 protein binds to POU5F1 promoter]] | affects binding|increases reaction | 16415856
|
| D014212 |
Tretinoin |
EHMT2 protein promotes the reaction [Tretinoin promotes the reaction [CBX1 protein binds to ZFP42 promoter]] | affects binding|increases reaction | 16415856
|
| D014212 |
Tretinoin |
EHMT2 protein promotes the reaction [Tretinoin results in increased methylation of POU5F1 promoter] | increases methylation|increases reaction | 16415856
|
| D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of EHMT2 mRNA | affects cotreatment|increases expression | 17183730
|
| D014635 |
Valproic Acid |
Valproic Acid results in decreased expression of EHMT2 mRNA | decreases expression | 19101580
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000008 |
Abdominal Neoplasms |
|
Sulindac |
5.50 | 14745880 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.28 | 14514962 11752688 15322242 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.28 | 8875741 |
| MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.91 | 19490988 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.94 | 17505938 |
| MESH:D058186 |
Acute Kidney Injury |
|
Sulindac |
4.29 | 7897758 |
| MESH:D055371 |
Acute Lung Injury |
|
Nickel |
4.56 | 16166738 |
| MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
7.19 | 17418594 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
7.19 | 14692618 |
| MESH:D000230 |
Adenocarcinoma |
|
Sulindac |
7.19 | 11910360 |
| MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
6.97 | 3712494 |
| MESH:D000236 |
Adenoma |
|
Sulindac |
6.97 | 10223192 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.37 | 16835633 |
| MESH:D011125 |
Adenomatous Polyposis Coli |
|
Sulindac |
4.58 | 16460482 11535846 19003578 11874996 17611924 12394442 15623613 |
| MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.53 | 21441931 |
| MESH:D000505 |
Alopecia |
|
Tretinoin |
3.60 | 15955085 |
| MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.43 | 15513908 |
| MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.23 | 17688650 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.93 | 11748828 |
| MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.84 | 10982225 |
| MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.55 | 17497229 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.45 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.16 | 15885639 |
| MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.16 | 16412693 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
4.65 | 15570426 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.65 | 16292516 |
| MESH:D001249 |
Asthma |
|
Ozone |
4.93 | 17854713 16373670 |
| MESH:D001249 |
Asthma |
|
Tretinoin |
4.93 | 16456186 |
| MESH:D055963 |
Asthma, Aspirin-Induced |
|
Aspirin |
4.68 | 20485159 12372130 |
| MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.85 | 18445737 |
| MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.85 | 20603192 18396377 18558336 17157402 18985861 18940202 15238991 18775368 19232924 16609825 17507914 18177632 19460635 17688650 18316065 |
| MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.39 | 16935849 |
| MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.02 | 1440618 11289319 |
| MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.06 | 20046352 17594078 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.88 | 12125929 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.88 | 16206674 16197459 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.79 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.98 | 15746008 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.98 | 8888407 |
| MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.70 | 14601052 |
| MESH:D001913 |
Bowen's Disease |
|
Sulindac |
5.35 | 11207687 |
| MESH:D001932 |
Brain Neoplasms |
|
Aspirin |
9.08 | 15481559 |
| MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
9.08 | 17150277 |
| MESH:D001943 |
Breast Neoplasms |
|
Aspirin |
3.77 | 15161893 |
| MESH:D001943 |
Breast Neoplasms |
|
decitabine |
3.77 | 19208741 18320071 |
| MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
3.77 | 16096432 16322301 18695136 16826403 16264153 18234424 18628466 15634643 15994142 16935488 15993339 15692762 15939500 17369602 15136595 16115903 18382427 16595493 19526202 17983394 15567936 17426702 15668708 11325840 |
| MESH:D001943 |
Breast Neoplasms |
|
Nickel |
3.77 | 15986119 |
| MESH:D001943 |
Breast Neoplasms |
|
Sulindac |
3.77 | 16642371 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.77 | 20435547 |
| MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
3.77 | 16873071 16443354 16166294 |
| MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.66 | 19059883 18315731 16777450 18417511 14754758 15516495 17626835 |
| MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.58 | 16813970 |
| MESH:D002100 |
Cachexia |
|
Ozone |
4.73 | 16183385 |
| MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.81 | 16051944 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.78 | 16835633 |
| MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.16 | 16168501 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
8.84 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
8.84 | 7296757 3581430 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
8.84 | 3084413 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
8.84 | 17876044 18059187 16023760 16234567 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
8.84 | 1917145 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
6.52 | 7296757 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.52 | 1485588 16201981 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
7.58 | 19215824 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
7.58 | 6189445 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.58 | 16096774 16051514 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.35 | 18850075 18670907 16120746 |
| MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.51 | 17007740 16109756 15792986 15505089 17974986 15476868 15811867 17308081 16278810 17519947 16952015 16731534 17928571 16651473 16612575 17351982 17382496 17924179 16455267 16269455 16242529 18627295 17131338 16364871 17329180 |
| MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.94 | 16243910 17334414 |
| MESH:D002386 |
Cataract |
|
Acetaminophen |
7.18 | 10977129 |
| MESH:D002386 |
Cataract |
|
Tretinoin |
7.18 | 17460283 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.61 | 6135515 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
6.61 | 7505956 |
| MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.58 | 16129372 |
| MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.70 | 20734317 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.14 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
7.81 | 9022650 19486331 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.81 | 16919318 15861022 17681005 17110522 16105132 11677210 17333356 |
| MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.16 | 16461808 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.74 | 12621046 15340226 16354765 8697196 15668235 |
| MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.74 | 9407595 |
| MESH:D003092 |
Colitis |
|
Tretinoin |
3.69 | 17035595 |
| MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
8.40 | 15037631 |
| MESH:D003110 |
Colonic Neoplasms |
|
Aspirin |
8.40 | 12411196 |
| MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
8.40 | 17616700 |
| MESH:D003110 |
Colonic Neoplasms |
|
Sulindac |
8.40 | 12458338 12902858 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Aspirin |
4.87 | 17047198 |
| MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
4.87 | 18981723 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
4.87 | 18802399 18259882 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Sulindac |
4.87 | 10666051 11197048 11076880 18059344 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.04 | 17141729 14669216 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.75 | 20055451 10048152 15322242 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.75 | 8800419 10589399 14991402 17551590 9125849 16925845 9664655 9224671 9211117 9142499 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.75 | 8888407 17688650 16575769 |
| MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.00 | 18551238 |
| MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
7.20 | 2524372 18759878 8970840 12868966 11298694 8156756 11906362 14531868 |
| MESH:D017449 |
Dermatitis, Allergic Contact |
|
Nickel |
7.20 | 19470301 17100760 17244072 |
| MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
9.48 | 2952479 3621924 |
| MESH:D003877 |
Dermatitis, Contact |
|
Nickel |
9.48 | 2952479 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.66 | 17107852 |
| MESH:D003930 |
Diabetic Retinopathy |
|
Sulindac |
5.16 | 17621415 12861449 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
15.19 | 21346803 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
15.19 | 18692083 6482804 8291058 11289319 18289764 18648102 7440962 9022650 9328219 9653073 16192314 6679447 1440618 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
15.19 | 19923254 16177239 12540782 15968718 16485898 18713872 12153990 16109766 10774834 11739529 14550746 17906064 12594235 11743745 17562736 11834606 2444490 19085960 19370779 14725611 16393943 12705907 10663392 18071297 19164858 16081117 11529661 11461765 12392966 19416960 11421492 16781746 12958197 10915739 15619225 19739265 19420014 16227642 17522070 11287661 14986274 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
15.19 | 17416283 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
15.19 | 20420201 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
15.19 | 1733752 19641884 |
| MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.10 | 19426721 |
| MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
8.06 | 18602426 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.06 | 11462148 |
| MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.03 | 1851702 |
| MESH:D004487 |
Edema |
|
Aspirin |
7.00 | 17259670 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.00 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.95 | 18230668 15322242 16714409 |
| MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.95 | 18230668 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.17 | 12538720 |
| MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.12 | 19294695 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
7.54 | 17359293 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.54 | 16569247 |
| MESH:D004715 |
Endometriosis |
|
Sulindac |
9.13 | 15652904 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.13 | 10568697 9294722 |
| MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.16 | 18037988 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.14 | 17275665 3659116 |
| MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.92 | 3922381 16628512 |
| MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.92 | 20417680 18234410 |
| MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.57 | 7562514 6426943 6254150 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.28 | 7750514 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.06 | 3659116 |
| MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.76 | 3581430 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Sulindac |
4.76 | 12235107 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.78 | 11564622 |
| MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.78 | 16938888 9664655 |
| MESH:D005234 |
Fatty Liver |
|
arsenite |
13.09 | 18296743 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
13.09 | 15345470 |
| MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
13.09 | 19224547 14986274 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.44 | 11858732 |
| MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.89 | 16575769 |
| MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.11 | 8888407 18558336 |
| MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.02 | 6705139 |
| MESH:D018221 |
Fibromatosis, Abdominal |
|
Sulindac |
5.47 | 14745880 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
11.76 | 19069698 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Sulindac |
11.76 | 19069698 |
| MESH:D005355 |
Fibrosis |
|
arsenite |
14.77 | 18296743 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.77 | 20067830 |
| MESH:D005355 |
Fibrosis |
|
Tretinoin |
14.77 | 17994277 |
| MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.68 | 16983495 |
| MESH:D005764 |
Gastroesophageal Reflux |
|
Sulindac |
4.99 | 11910360 |
| MESH:D005909 |
Glioblastoma |
|
Aspirin |
11.95 | 12870263 |
| MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
11.95 | 17150277 |
| MESH:D005909 |
Glioblastoma |
|
Tretinoin |
11.95 | 17312396 |
| MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.02 | 7505956 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.59 | 10696789 |
| MESH:D006261 |
Headache |
|
Aspirin |
4.96 | 15240983 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
12.91 | 19215824 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
12.91 | 15692506 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
12.91 | 16096774 |
| MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.16 | 16084493 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.50 | 11294989 10048152 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.50 | 14991402 9664655 |
| MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.47 | 16495754 16330681 16244372 17888722 18006777 16144979 14766674 16707910 17875725 12587719 18674790 16244371 16879835 |
| MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.33 | 17481944 |
| MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.88 | 15692506 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.32 | 11000095 |
| MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.50 | 6705139 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.88 | 15340226 12621046 16120746 |
| MESH:D015658 |
HIV Infections |
|
Nickel |
3.80 | 17263646 |
| MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.39 | 15147373 17606976 18501091 |
| MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.86 | 17688650 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.05 | 15340226 16354765 8697196 16959395 18606429 |
| MESH:D012001 |
Hyperacusis |
|
Aspirin |
5.76 | 15240983 |
| MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.57 | 16870215 |
| MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.57 | 16870215 |
| MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.55 | 16778211 |
| MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.92 | 15034207 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.90 | 18850075 18670907 |
| MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.61 | 16612254 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.80 | 16945680 16569931 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.44 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
decitabine |
6.67 | 17581917 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.67 | 17937319 |
| MESH:D007249 |
Inflammation |
|
Nickel |
8.48 | 16166738 |
| MESH:D007249 |
Inflammation |
|
Sulindac |
8.48 | 3291741 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.48 | 12878042 12200463 |
| MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.75 | 17994277 |
| MESH:D007414 |
Intestinal Neoplasms |
|
Sulindac |
4.62 | 10223192 12584176 10213222 12351151 12628509 12663524 |
| MESH:D007417 |
Intestinal Polyps |
|
Sulindac |
4.97 | 11245490 12394442 |
| MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.02 | 8074119 9022650 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.87 | 16580747 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.87 | 15992940 17551590 |
| MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.02 | 12587719 15629191 |
| MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.02 | 15369732 15699352 16775033 |
| MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.13 | 16707910 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.30 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.30 | 6582329 |
| MESH:D007938 |
Leukemia |
|
decitabine |
6.39 | 18980019 19235587 |
| MESH:D007938 |
Leukemia |
|
Tretinoin |
6.39 | 17143497 |
| MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.16 | 16085563 |
| MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
9.50 | 19117987 17236224 18454857 |
| MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
9.50 | 16932348 16482212 19285840 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
6.13 | 19010910 18460780 17679729 18704418 19387464 18206229 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
6.13 | 17596541 16294345 19850784 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
6.13 | 16294345 17596541 |
| MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.46 | 18055864 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.14 | 9834237 12679006 17712046 16331271 17361223 17506722 16823087 16140955 19029980 16766008 16788101 17368321 19075265 17217047 16935935 15748426 19035177 17294898 16891316 17649720 17107899 19642359 17339181 19225113 17301526 |
| MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.29 | 9224671 |
| MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
3.41 | 18296743 |
| MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
8.46 | 15034207 9327722 |
| MESH:D008105 |
Liver Cirrhosis, Biliary |
|
Sulindac |
8.46 | 12468960 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
3.49 | 16439617 16595196 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.49 | 12878042 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.49 | 16248980 18397230 |
| MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
4.23 | 12587719 12969438 11587558 19014921 16611625 19460945 16610002 19784758 |
| MESH:D008107 |
Liver Diseases |
|
Sulindac |
4.23 | 14986274 16867024 |
| MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.22 | 16871587 17185352 |
| MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.34 | 7678174 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.34 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
14.01 | 6135515 2876786 2876784 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
14.01 | 6587162 598648 1399818 3712494 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
14.01 | 16842330 17085340 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.01 | 12151625 |
| MESH:D008171 |
Lung Diseases |
|
Ozone |
3.36 | 19066396 8266340 |
| MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.26 | 17228818 |
| MESH:D055370 |
Lung Injury |
|
Ozone |
3.83 | 20417186 |
| MESH:D008175 |
Lung Neoplasms |
|
arsenite |
6.59 | 16809336 |
| MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
6.59 | 17418594 6189445 |
| MESH:D008175 |
Lung Neoplasms |
|
Ozone |
6.59 | 8597069 7614698 |
| MESH:D008175 |
Lung Neoplasms |
|
Sulindac |
6.59 | 19359593 15713900 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.59 | 11884234 19555203 |
| MESH:D008223 |
Lymphoma |
|
decitabine |
7.67 | 19470736 |
| MESH:D008223 |
Lymphoma |
|
Doxorubicin |
7.67 | 16098063 |
| MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.77 | 17654614 |
| MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.55 | 15621674 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.02 | 15458769 |
| MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.78 | 17453147 |
| MESH:D008545 |
Melanoma |
|
decitabine |
7.34 | 16505122 17785578 |
| MESH:D008545 |
Melanoma |
|
Doxorubicin |
7.34 | 16827129 |
| MESH:D008545 |
Melanoma |
|
Sulindac |
7.34 | 16642371 |
| MESH:D008545 |
Melanoma |
|
Tretinoin |
7.34 | 16752155 |
| MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.55 | 19513568 |
| MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.41 | 16940565 |
| MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.05 | 17638057 |
| MESH:D008679 |
Metaplasia |
|
Ozone |
5.11 | 10496685 |
| MESH:D008881 |
Migraine Disorders |
|
Aspirin |
7.81 | 15240983 |
| MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
7.81 | 18765137 18803445 |
| MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.48 | 15792986 |
| MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.78 | 17415656 |
| MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.33 | 18172295 |
| MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.01 | 8888407 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
12.27 | 18608210 19157545 16882708 19010910 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
12.27 | 17596541 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
12.27 | 17596541 |
| MESH:D009203 |
Myocardial Infarction |
|
Aspirin |
6.20 | 12692751 |
| MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
6.20 | 15857846 19429709 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.00 | 12213967 |
| MESH:D009325 |
Nausea |
|
Aspirin |
5.21 | 15240983 |
| MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.85 | 18551238 7678174 |
| MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.82 | 3581430 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.82 | 18259882 |
| MESH:D009369 |
Neoplasms |
|
decitabine |
5.15 | 19116145 19470736 17925555 |
| MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.15 | 16946489 16594593 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
4.40 | 15738583 |
| MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.75 | 16899518 16636307 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.98 | 16889571 15640375 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.46 | 14600291 |
| MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.46 | 9125849 |
| MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
12.05 | 6679447 |
| MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
12.05 | 9142499 |
| MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
12.05 | 16359493 8888407 |
| MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.25 | 15555623 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
8.46 | 18514411 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Sulindac |
8.46 | 17266991 16850258 |
| MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.82 | 16049721 |
| MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
8.82 | 6482804 4026338 |
| MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.02 | 3988306 |
| MESH:D010003 |
Osteoarthritis |
|
Aspirin |
4.04 | 7009135 |
| MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.09 | 15930896 |
| MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
4.94 | 19331143 19259094 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
4.94 | 16936753 |
| MESH:D010146 |
Pain |
|
Acetaminophen |
16.03 | 16870215 |
| MESH:D010146 |
Pain |
|
Aspirin |
16.03 | 6995502 6363464 |
| MESH:D010146 |
Pain |
|
Sulindac |
16.03 | 3291741 |
| MESH:D010146 |
Pain |
|
Tretinoin |
16.03 | 16870215 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
8.73 | 19294695 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Sulindac |
8.73 | 11504793 16820089 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
8.73 | 15976015 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.67 | 11578682 |
| MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.47 | 7296757 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.25 | 12520081 |
| MESH:D010438 |
Peptic Ulcer Hemorrhage |
|
Aspirin |
5.53 | 11156591 |
| MESH:D010538 |
Peritonitis |
|
Ozone |
4.12 | 16369182 |
| MESH:D020795 |
Photophobia |
|
Aspirin |
5.76 | 15240983 |
| MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.47 | 6228378 |
| MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.16 | 17983394 |
| MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.16 | 17638057 |
| MESH:D011014 |
Pneumonia |
|
Ozone |
4.39 | 18381685 18929643 18007984 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.54 | 18163543 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.44 | 11896295 11118676 11222880 11399792 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.44 | 20603192 |
| MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.71 | 17616702 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.56 | 16729912 15749863 15897917 16868541 18437689 16888761 |
| MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.59 | 16636307 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.30 | 16919318 15861022 |
| MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.54 | 11422049 12752131 |
| MESH:D011625 |
Pterygium |
|
Tretinoin |
4.78 | 16723453 |
| MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.21 | 17922066 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.82 | 18990726 |
| MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.36 | 3692021 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
18.43 | 19155313 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
18.43 | 16116481 16283617 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
18.43 | 19155313 |
| MESH:D012220 |
Rhinitis |
|
Aspirin |
4.35 | 12372130 |
| MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.97 | 15625365 17203757 16767912 18313854 15675481 17710206 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.23 | 14601052 16326096 |
| MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.78 | 17846226 |
| MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.07 | 15737665 19110320 |
| MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.89 | 18551238 |
| MESH:D012640 |
Seizures |
|
Valproic Acid |
5.89 | 1511512 11738929 14763951 15475178 3137016 17978042 11044598 16876388 |
| MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Aspirin |
5.25 | 12269725 |
| MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
9.41 | 15692506 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.41 | 16192470 |
| MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.41 | 16467112 |
| MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.55 | 16767912 17203757 15625365 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.94 | 16709447 |
| MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.76 | 19490988 |
| MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.54 | 12833885 |
| MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.54 | 19037991 |
| MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.54 | 17261132 |
| MESH:D020521 |
Stroke |
|
Aspirin |
4.36 | 16403987 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.60 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Aspirin |
9.14 | 17672075 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
9.14 | 15669648 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.90 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
17.00 | 1399818 6582329 3712494 7505956 6587162 |
| MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
17.00 | 17967635 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
17.00 | 16010429 17909728 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
17.00 | 16026305 17045167 |
| MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.77 | 16051514 |
| MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.23 | 17262798 |
| MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.21 | 16040207 |
| MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.51 | 3119515 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
11.89 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.89 | 8074119 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
11.89 | 17616700 19087683 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
11.89 | 17653716 |
| MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.63 | 8888407 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.31 | 10091137 |
| MESH:D014581 |
Urticaria |
|
Acetaminophen |
8.84 | 10982225 |
| MESH:D014581 |
Urticaria |
|
Aspirin |
8.84 | 10982225 20485159 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.66 | 16129372 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
9.61 | 14692618 |
| MESH:D014594 |
Uterine Neoplasms |
|
Sulindac |
9.61 | 18645019 |
| MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
12.83 | 17785578 |
| MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
12.83 | 16752155 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.59 | 12125929 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.52 | 14671159 15869587 |
| MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.21 | 17334414 17638931 17678736 16364871 |
| MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.04 | 16761959 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.25 | 15886252 |
| MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.95 | 16287080 |